Academic Bibliography

Search 200 years of publications by Ghent University researchers.

Publication type

Year

Classification

Organization

Show Sort by

Your filters: cql: author="WALEWSKI, J" or (type exact bookEditor and editor="WALEWSKI, J")

Add to list
- Conference Paper
- C3
CVP plus rituximab compared to CVP alone in previously untreated patients with follicular lymphoma: Impact of baseline prognostic factors

K IMRIE, A BELCH, R PETTENGELL, A RUEDA, J MCKENDRICK, P SOLAL-CELIGNY, Fritz Offner (UGent) , I BENCE-BUCKLER, J WALEWSKI, J RAPOSO, et al.

(2005) ANNALS OF ONCOLOGY. 16. p.109-110
Add to list
- Conference Paper
- C3
Mabthera (Rituximab) plus CVP chemotherapy for first-line treatment of stage III/IV follicular non-Hodgkin's lymphoma (NHL): Confirmed efficacy with longer follow-up

P SOLAL-CELIGNY, K IMRIE, A BELCH, KS ROBINSON, D CUNNINGHAM, A RUEDA, J CATALANO, Fritz Offner (UGent) , J WALEWSKI, J RAPOSO, et al.

(2005) BLOOD. 106(11).
Add to list
- Journal Article
- A1
CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma

R MARCUS, K IMRIE, A BELCH, D CUNNINGHAM, E FLORES, J CATALANO, P SOLAL-CELIGNY, Fritz Offner (UGent) , J WALEWSKI, J RAPOSO, et al.

(2005) BLOOD. 105(4). p.1417-1423
Add to list
- Conference Paper
- C3
An international multi-centre, randomized, open-label, phase III trial comparing rituximab added to CVP chemotherapy to CVP chemotherapy alone in untreated stage III/IV follicular non-Hodgkins lymphoma

R MARCUS, K IMRIE, A BELCH, D CUNNINGHAM, E FLORES, J CATALANO, P SOLAL-CELIGNY, Fritz Offner (UGent) , J WALEWSKI, J RAPOSO, et al.

(2003) BLOOD. 102(11).